Recalls for TRUFILL® n-BCA Liquid Embolic System

FDA Classifies Worldwide Voluntary Correction Notice on TRUFILL® n-BCA Liquid Embolic System as Class I Recall
01/22/2014 Food Recall

Codman Neuro announced today that the U.S. Food and Drug Administration (FDA) has classified the recently initiated medical device correction notice related to the TRUFILL® n-BCA Liquid Embolic System as a Class I recall.

  • Company:
    Codman Neuro
  • Problem
    Incorrect Statement In The Package Instructions For Use